Entrada Therapeutics, Inc.

NASDAQ:TRDA

Biotechnology

Healthcare
$4.96 +0.37%

+$0.03 today

Market cap
$194.19M
Beta
-0.26
P/E (TTM)
-1.7
EPS (TTM)
-$3.97
52W Low $4.93High $16.45

Volume 0.43M

Average 0.36M

Private 5-step workspace

Build a TRDA investment thesis

Turn Entrada Therapeutics, Inc. research into a structured decision across business quality, moat, management, intrinsic value, and synthesis.

Log in to save your stock analysis
Your answers are private and saved per stock, so you can come back to the thesis later.